» Articles » PMID: 17497629

Levels of Error Processing in Huntington's Disease: a Combined Study Using Event-related Potentials and Voxel-based Morphometry

Overview
Journal Hum Brain Mapp
Publisher Wiley
Specialty Neurology
Date 2007 May 15
PMID 17497629
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's Disease (HD) is a neurogenetic disorder accompanied by an atrophy of the striatum and hence of the dopaminergic (DA) system. Neural processes subserving error processing presumably depend on the DA system. We assessed error processing in manifest HD and in presymptomatic HD-gene-mutation-carriers (pHD) with event-related potentials reflecting error processing (the error negativity or error-related negativity and the error positivity derived from a flanker-task. We found a reduction of the Ne in the case of HD compared to pHD reflecting dopamine system pathology. Despite the Ne being reduced in HD, behavioral adaptation was possible. In addition, the error-rates did not differ between the groups. Optimized voxel-based morphometry revealed that grey matter volume in the medial frontal gyrus is correlated with the Ne amplitude in symptomatic patients. In addition, the effect of a Ne-reduction was related to the grey matter underneath the medial frontal gyrus, which is in line with two theories of the Ne. In contrast, the Pe did not differ between the groups, suggesting that the Pe is decoupled from the DA system. Interestingly we found a reduction of a late slow negativity on correct responses, which possibly reflects decreased preparatory processes in HD compared to pHD as induced by the DA alterations in HD. In conclusion a deterioration in error processing in HD compared to pHD is mainly reflected by the Ne. The deterioration might rely on two factors: a neurofunctional and a neuroanatomical.

Citing Articles

Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.

Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani A, Mohamed W Biology (Basel). 2025; 14(2).

PMID: 40001897 PMC: 11852324. DOI: 10.3390/biology14020129.


Association Study of Serotonin 1A Receptor Gene, Personality, and Anxiety in Women with Alcohol Use Disorder.

Boron A, Suchanecka A, Chmielowiec K, Chmielowiec J, Lachowicz M, Stronska-Pluta A Int J Mol Sci. 2024; 25(12).

PMID: 38928270 PMC: 11203476. DOI: 10.3390/ijms25126563.


The neurophysiology of continuous action monitoring.

Wilken S, Bottcher A, Adelhofer N, Raab M, Hoffmann S, Beste C iScience. 2023; 26(7):106939.

PMID: 37332673 PMC: 10275727. DOI: 10.1016/j.isci.2023.106939.


The gray matter morphology associated with the electrophysiological response to errors in individuals with high trait anxiety.

Fang L, Andrzejewski J, Carlson J Int J Psychophysiol. 2022; 184:76-83.

PMID: 36581044 PMC: 10125723. DOI: 10.1016/j.ijpsycho.2022.12.007.


Methamphetamine Users Show No Behavioral Deficits in Response Selection After Protracted Abstinence.

Bensmann W, Ernst J, Radle M, Opitz A, Beste C, Stock A Front Psychiatry. 2019; 10:823.

PMID: 31803080 PMC: 6877501. DOI: 10.3389/fpsyt.2019.00823.


References
1.
Beglinger L, Nopoulos P, Jorge R, Langbehn D, Mikos A, Moser D . White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol. 2005; 18(2):102-7. DOI: 10.1097/01.wnn.0000152205.79033.73. View

2.
Band G, Kok A . Age effects on response monitoring in a mental-rotation task. Biol Psychol. 2000; 51(2-3):201-21. DOI: 10.1016/s0301-0511(99)00038-1. View

3.
Verleger R, Wascher E, Arolt V, Daase C, Strohm A, Kompf D . Slow EEG potentials (contingent negative variation and post-imperative negative variation) in schizophrenia: their association to the present state and to Parkinsonian medication effects. Clin Neurophysiol. 1999; 110(7):1175-92. DOI: 10.1016/s1388-2457(99)00023-1. View

4.
Reading S, Dziorny A, Peroutka L, Schreiber M, Gourley L, Yallapragada V . Functional brain changes in presymptomatic Huntington's disease. Ann Neurol. 2004; 55(6):879-83. DOI: 10.1002/ana.20121. View

5.
Augood S, Faull R, Emson P . Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol. 1997; 42(2):215-21. DOI: 10.1002/ana.410420213. View